Focuses on the critical role of pharmacists in the management of infectious diseases, highlighting prevention, management, and treatment. Chapters cover central nervous system infections, gastrointestinal infections, endocarditis, fungal infections, viral infections, malaria, amebiasis, giardiasis, dengue fever, and urinary tract infections.
Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care, this new series of handbooks showcases the expanded roles and responsibilities of pharmacists. It is the first of its kind to provide comprehensive information about evidence-based pharmacist care across a wide range of healthcare issues, providing the latest research, guidelines, and up-to-date best practices.
Volume 5: System-Specific Infections provides an in-depth look at various infections, ranging from common to complex, and the impact of pharmacist-led care in these areas. Each chapter is dedicated to a specific type of infection and highlights the vital role pharmacists play in the prevention, management, and treatment of infectious diseases. Chapters cover central nervous system infections, gastrointestinal infections, endocarditis, fungal infections, viral infections, malaria, amebiasis, giardiasis, dengue fever, and urinary tract infections.
Volumes in Handbooks of Evidence-Based Pharmacist Care
Volume 1: Cardiovascular Diseases
Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders
Volume 3: Gastrointestinal Diseases and Disorders
Volume 4: Arthritis and Psychiatric Diseases and Disorders
Volume 5: System-Specific Infections
Volume 6: Widespread and Transmissible Infections
Volume 7: Skin Diseases and Conditions
Volume 8: Neurological, Hematological, and Urological Diseases and Disorders
Volume 9: Oncological Diseases and Disorders
Volume 10: Diseases and Disorders of Special Populations
Volume 11: Pharmacist Care in Special Services
Volume 12: Advanced Practices in Pharmacist Care
Volume 13: Pharmacist Skills and Competencies
Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World
Preface
1. Evidence-Based Pharmacist Care (Clinical, Economic, and
Humanistic Impact): Central Nervous System Infections
2. Evidence-Based
Pharmacist Care (Clinical, Economic, and Humanistic Impact): Gastrointestinal
Infections
3. Evidence-Based Pharmacist Care (Clinical, Economic, and
Humanistic Impact): Endocarditis
4. Evidence-Based Pharmacist Care (Clinical,
Economic, and Humanistic Impact): Fungal Infections
5. Evidence-Based
Pharmacist Care (Clinical, Economic, and Humanistic Impact): Viral Infections
6. Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic
Impact): Malaria
7. Evidence-Based Pharmacist Care (Clinical, Economic, and
Humanistic Impact): Amebiasis
8. Evidence-Based Pharmacist Care (Clinical,
Economic, and Humanistic Impact): Giardiasis
9. Evidence-Based Pharmacist
Care (Clinical, Economic, and Humanistic Impact): Dengue Fever
10.
Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact):
Urinary Tract Infections Index
Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patient care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.
